Search research articles
Contact Us
Filters
Showing results (11-20 of 22) with videos related to
Page
of 3
Sort By:
The International Journal on Drug Policy
|
March 24, 2024
Trends in opioid toxicities among people with and without opioid use disorder and the impact of the COVID-19 pandemic in Ontario, Canada: A population-based analysis
Shaleesa Ledlie, Mina Tadrous, Ahmed M Bayoumi, et al.
The International Journal on Drug Policy
|
June 29, 2025
Changing trends in safer opioid supply uptake, dose and hydromorphone volume in Ontario: A population-based cross-sectional study
Felix Xu, Tianru Wang, Gillian Kolla, et al.
BMJ Public Health
|
November 20, 2025
Initiation of opioid agonist treatment following hospital-treated opioid toxicities and the risk of repeat events in Ontario, Canada: a cohort study using inverse probability of treatment weights
Shaleesa Ledlie, Mina Tadrous, Ahmed M Bayoumi, et al.
Harm Reduction Journal
|
November 11, 2025
Exploring disparities: a regional analysis of harm reduction supply distribution and opioid-related deaths across Ontario's Public Health Units
Shaleesa Ledlie, Kristy Scarfone, Dana Shearer, et al.
PLOS Mental Health
|
February 9, 2026
Patient and Prescriber characteristics associated with return to daily-dispense methadone: A multilevel cohort study
Ria Garg, Shaleesa Ledlie, Daniel McCormack, et al.
Journal of Substance Use and Addiction Treatment
|
December 24, 2024
Trends, characteristics, and circumstances surrounding stimulant toxicity deaths in Ontario, Canada from 2018 to 2021
Shaleesa Ledlie, Pamela Leece, Joanna Yang, et al.
Plos One
|
May 23, 2025
The changing role of substances: trends, characteristics of individuals and prior healthcare utilization among individuals with accidental substance-related toxicity deaths in Ontario Canada
Shaleesa Ledlie, Alice Holton, Pamela Leece, et al.
The International Journal on Drug Policy
|
July 10, 2023
Assessing the impact of the slow-release oral morphine drug shortages in Ontario, Canada: A population-based time series analysis
Shaleesa Ledlie, Mina Tadrous, Daniel McCormack, et al.
Clinical Pharmacology and Therapeutics
|
January 27, 2026
Measuring the Impact of the Substitution of Innovator Biologics With Biosimilars on Uptake and Costs Among Ontario Public Drug Benefit Recipients
Anita Iacono, Martin K H Ho, Joanna Yang, et al.
Journal of Addiction Medicine
|
June 3, 2026
Opioid Agonist Treatment Use Among First Nation Peoples in Ontario, Canada: A Repeated Cross-sectional Study of Prevalence Trends From 2013 to 2023
Nevena Rebić, Shaleesa Ledlie, Bisola Hamzat, et al.
Page
of 3
Search research articles
Search
Showing results (11-20 of 22) with videos related to
Sort By:
Page
of 3
The International Journal on Drug Policy
|
March 24, 2024
Trends in opioid toxicities among people with and without opioid use disorder and the impact of the COVID-19 pandemic in Ontario, Canada: A population-based analysis
Shaleesa Ledlie, Mina Tadrous, Ahmed M Bayoumi, et al.
The International Journal on Drug Policy
|
June 29, 2025
Changing trends in safer opioid supply uptake, dose and hydromorphone volume in Ontario: A population-based cross-sectional study
Felix Xu, Tianru Wang, Gillian Kolla, et al.
BMJ Public Health
|
November 20, 2025
Initiation of opioid agonist treatment following hospital-treated opioid toxicities and the risk of repeat events in Ontario, Canada: a cohort study using inverse probability of treatment weights
Shaleesa Ledlie, Mina Tadrous, Ahmed M Bayoumi, et al.
Harm Reduction Journal
|
November 11, 2025
Exploring disparities: a regional analysis of harm reduction supply distribution and opioid-related deaths across Ontario's Public Health Units
Shaleesa Ledlie, Kristy Scarfone, Dana Shearer, et al.
PLOS Mental Health
|
February 9, 2026
Patient and Prescriber characteristics associated with return to daily-dispense methadone: A multilevel cohort study
Ria Garg, Shaleesa Ledlie, Daniel McCormack, et al.
Journal of Substance Use and Addiction Treatment
|
December 24, 2024
Trends, characteristics, and circumstances surrounding stimulant toxicity deaths in Ontario, Canada from 2018 to 2021
Shaleesa Ledlie, Pamela Leece, Joanna Yang, et al.
Plos One
|
May 23, 2025
The changing role of substances: trends, characteristics of individuals and prior healthcare utilization among individuals with accidental substance-related toxicity deaths in Ontario Canada
Shaleesa Ledlie, Alice Holton, Pamela Leece, et al.
The International Journal on Drug Policy
|
July 10, 2023
Assessing the impact of the slow-release oral morphine drug shortages in Ontario, Canada: A population-based time series analysis
Shaleesa Ledlie, Mina Tadrous, Daniel McCormack, et al.
Clinical Pharmacology and Therapeutics
|
January 27, 2026
Measuring the Impact of the Substitution of Innovator Biologics With Biosimilars on Uptake and Costs Among Ontario Public Drug Benefit Recipients
Anita Iacono, Martin K H Ho, Joanna Yang, et al.
Journal of Addiction Medicine
|
June 3, 2026
Opioid Agonist Treatment Use Among First Nation Peoples in Ontario, Canada: A Repeated Cross-sectional Study of Prevalence Trends From 2013 to 2023
Nevena Rebić, Shaleesa Ledlie, Bisola Hamzat, et al.
Page
of 3